New Hampshire rabies titer bill stalls after sparking debate

A New Hampshire bill that would have loosened rabies booster requirements for some pets has become a flashpoint in the broader debate over vaccine exemptions, veterinary discretion, and public health. House Bill 1488 proposed allowing dogs, cats, and ferrets to qualify for a rabies immunization exemption if a veterinarian used antibody titer testing to document immunity after prior vaccination. The measure kept the initial vaccine requirement, but it opened the door to bypassing future boosters, making it unusual in a policy area where current vaccination status remains the legal benchmark. (bills.nhliberty.org)

The bill emerged against a backdrop of growing skepticism around vaccine mandates in parts of New Hampshire politics. Reporting from New Hampshire Bulletin said supporters framed the measure as a response to concerns about vaccine side effects and the burden of obtaining medical exemptions under current law. Under existing New Hampshire requirements, dogs, cats, and ferrets older than 3 months must receive an initial rabies vaccine and then boosters on the schedule set by the National Association of State Public Health Veterinarians’ compendium. (newhampshirebulletin.com)

As introduced, HB 1488 would have allowed two exemption tracks. One followed a more traditional medical-exemption route requiring a veterinarian’s recommendation signed by an American College of Veterinary Internal Medicine diplomate and the state veterinarian. The other was new: a single licensed veterinarian could recommend exemption after performing a baseline rabies titer before vaccination and a second titer 7 to 14 days later to establish that animal’s individual immune response. Future exemption testing would then have to show antibody levels equal to or higher than that post-vaccination baseline, with exemptions renewed annually. Animals exempted for medical reasons would face strict isolation, leash, and muzzle requirements, but animals exempted through titer-based demonstrated immunity would not. (bills.nhliberty.org)

That structure helps explain why the bill drew scrutiny. AAHA states that rabies vaccines are highly effective, that vaccine failures are rarely reported, and that antibody titer levels have not been established as correlates of protection for rabies. Its guidance says serologic testing is not considered a substitute for vaccination. The NASPHV compendium has long taken the same position, stating that evidence of circulating rabies antibodies should not be used as a substitute for current vaccination when managing exposures or determining booster needs. (aaha.org)

At the same time, the science around titers is nuanced enough to keep the issue alive. Kansas State’s rabies laboratory says challenge studies show currently vaccinated dogs and cats with antibody levels above 0.5 IU/mL survive more often than animals below that threshold, but the correlation is imperfect and rare failures have occurred above 0.5 IU/mL. The lab also notes that timing of the blood draw, assay standardization, and laboratory accreditation all matter, and that if titers are ever used in lieu of vaccination, standards for cutoff values, timing, and approved methods would need to be established first. In other words, the bill was trying to legislate around scientific and regulatory questions that veterinary and public health groups still consider unsettled. (ksvdl.org)

For veterinary teams, the practical stakes are broader than booster scheduling. Rabies status affects bite management, quarantine decisions, licensing, boarding, interstate movement, and client communication. Even where titers may be useful in research settings or for certain international import scenarios, U.S. domestic rabies control rules generally still turn on whether an animal is currently vaccinated under state law, not whether it has measurable antibodies. That means a titer-based exemption could create confusion for clinics if legal definitions, public health protocols, and client expectations drift apart. (restoredcdc.org)

The bill’s trajectory also matters. Citizens Count, which tracks New Hampshire legislation using state data, says HB 1488 did not become law and was placed in interim study, with the House vote recorded on March 11, 2026, and status updated March 31, 2026. That doesn’t end the issue. Interim study often signals that lawmakers want more testimony, more technical review, or a narrower rewrite before trying again. (citizenscount.org)

Why it matters: For veterinarians, HB 1488 is less about one state bill than about whether rabies policy could begin shifting from standardized revaccination schedules toward individualized immunity claims. That may appeal to some pet parents worried about adverse events, but it would also put more interpretive burden on practitioners in one of the most tightly regulated vaccine categories in companion animal medicine. Until public health authorities, veterinary associations, and regulators align on what level of serologic evidence is meaningful and how it should affect exposure management, most clinics will likely remain bound to the current framework: rabies titers can inform discussion, but they don’t replace legal vaccination status. (aaha.org)

What to watch: The next signal will be whether New Hampshire’s interim study produces a revised bill with narrower eligibility, stronger lab standards, or formal input from state veterinary and public health officials before the 2027 session. (citizenscount.org)